2
OUR PORTFOLIO AT A GLANCE Please see full Prescribing Information at makena.com 1 PHASE 1 PHASE 2 PHASE 3 Regulatory Review Approved/ Marketed Ciraparantag i Feraheme® (ferumoxytol injection) Please see full Prescribing Information including Boxed Warning at Feraheme.com AMAG-423 Digoxin Immune Fab (ovine) i Makena® (hydroxyprogesterone caproate injection) i. In clinical development; safety and efficacy of the product candidate has not been established. As of July 2020 © 2019 AMAG Pharmaceuticals, Inc. All rights reserved.

AMAG OnePager Portfolio 062626020.pptx - Read-Only€¦ · Title: Microsoft PowerPoint - AMAG_OnePager_Portfolio_062626020.pptx - Read-Only Author: MBegley Created Date: 7/9/2020

  • Upload
    others

  • View
    0

  • Download
    0

Embed Size (px)

Citation preview

Page 1: AMAG OnePager Portfolio 062626020.pptx - Read-Only€¦ · Title: Microsoft PowerPoint - AMAG_OnePager_Portfolio_062626020.pptx - Read-Only Author: MBegley Created Date: 7/9/2020

OUR PORTFOLIO AT A GLANCE

Please see full Prescribing Information at makena.com

1

PHASE 1 PHASE 2 PHASE 3 Regulatory Review

Approved/Marketed

Ciraparantagi

Feraheme® (ferumoxytol injection) Please see full Prescribing Information including Boxed Warning at Feraheme.com

AMAG-423Digoxin Immune Fab (ovine)i

Makena® (hydroxyprogesterone caproate injection)

i. In clinical development; safety and efficacy of the product candidate has not been established.

As of July 2020

© 2019 AMAG Pharmaceuticals, Inc. All rights reserved.

Page 2: AMAG OnePager Portfolio 062626020.pptx - Read-Only€¦ · Title: Microsoft PowerPoint - AMAG_OnePager_Portfolio_062626020.pptx - Read-Only Author: MBegley Created Date: 7/9/2020

www.amagpharma.com

© 2019 AMAG Pharmaceuticals, Inc. All rights reserved.